Prostatic Neoplasms: all 6,484 studies
Page 46 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate CancerStatus unknownNCT02651896
- Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer IndicationsCompletedNCT02649790Phase 1/2
- Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) InjectionWithdrawnNCT02647983Phase 1
- Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsCompletedNCT02646319Early Phase 1
- Randomized AmnioFix Study During Radical ProstatectomyWithdrawnNCT02645591Phase 2
- Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide AloneTerminatedNCT02640534Phase 2
- A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility StudyCompletedNCT02640131Not applicable
- Hypofractionated Radiosurgery for Localised Prostate CancerCompletedNCT02635256Not applicable
- Hemi-Ablative Prostate BrachytherapyCompletedNCT02632669Not applicable
- Supervised Group Based Exercise for Men With Prostate Cancer on Androgen Deprivation TherapyCompletedNCT02631681Not applicable
- Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATETStatus unknownNCT02631616Phase 1
- Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone.CompletedNCT02630641
- HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate CancerCompletedNCT02628041Phase 2
- Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate CancerCompletedNCT02625857Phase 1
- MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer PatientsActive, not recruitingNCT02623933Not applicable
- A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate CancerStatus unknownNCT02623647Not applicable
- Physical Activity Intervention in African American Men After Radical ProstatectomyWithdrawnNCT02621684Not applicable
- Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCsWithdrawnNCT02621190Phase 2
- Impact of Yoga As Complementary Therapy in Patients Undergoing Radical ProstatectomyCompletedNCT02620033Not applicable
- Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate CancerCompletedNCT02618200Not applicable
- Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life AssessmentCompletedNCT02618161Not applicable
- Endocrine Therapy With or Without Cryoablation for Stage IV Prostate CancerStatus unknownNCT02615223Not applicable
- Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate CancerCompletedNCT02615067Phase 3
- CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate CancerCompletedNCT02613273Not applicable
- A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate CancerWithdrawnNCT02608359
- Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate CancerTerminatedNCT02606123Phase 1/2
- Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate CancerStatus unknownNCT02605226Not applicable
- Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing SurgeryCompletedNCT02603965Phase 1
- Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted SurgeryStatus unknownNCT02600481Not applicable
- Focal Laser Ablation of Low to Intermediate Prostate Cancer TumorsCompletedNCT02600156Not applicable
- Salvage Radiotherapy After Radical ProstatectomyStatus unknownNCT02597725
- Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)Active, not recruitingNCT02594072Not applicable
- Multi-target Tracking in Prostate Radiotherapy Using MLC and KIMWithdrawnNCT02588846Not applicable
- The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer PatientWithdrawnNCT02588404
- Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - EnzalutamideCompletedNCT02588001Not applicable
- Tumor Hypoxia With HX4 PET in Several DiseasesTerminatedNCT02584400Phase 2
- Biparametric MRI for Detection of Significant Prostate CancerCompletedNCT02584179Not applicable
- A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc StudyCompletedNCT02578797Phase 1
- Dose Escalation Study of Preoperative SBRT for High Risk Prostate CancerCompletedNCT02572284Phase 1
- Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate CancerCompletedNCT02570919Not applicable
- Study of TAS3681 in Metastatic Castration Resistant Prostate CancerCompletedNCT02566772Phase 1
- MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate CaTerminatedNCT02564549Not applicable
- Stereotactic Radiotherapy for Oligometastatic Prostate CancerStatus unknownNCT02563691Phase 1/2
- Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate CancerActive, not recruitingNCT02560181Not applicable
- Physical Therapy for Men Undergoing ProstatectomyActive, not recruitingNCT02558946Not applicable
- J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell CountsCompletedNCT02552394Phase 1
- Lung Protective Ventilation During Robotic Assisted ProstatectomyCompletedNCT02551341Phase 3
- A Registry of Participants With Prostate Cancer in AsiaCompletedNCT02546908
- Hypofractionated Whole Pelvic Radiotherapy of the ProstateWithdrawnNCT02546427Not applicable
- Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer AggressivenessStatus unknownNCT02545881
- Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)CompletedNCT02543255Phase 2
- Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) AnaloguesCompletedNCT02542501
- Effect of Dexmedetomidine on Heart-rate Corrected QT(QTc) Interval Prolongation During Robotic-assisted Laparoscopic Radical Prostatectomy -Randomized Blind Clinical Trial-CompletedNCT02536014Not applicable
- Cellular Effect of Cholesterol-Lowering Prior to Prostate RemovalCompletedNCT02534376Early Phase 1
- Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate CancerCompletedNCT02532114Phase 1
- Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission TomographyNo longer availableNCT02531672
- An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASActive, not recruitingNCT02531516Phase 3
- A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate CancerCompletedNCT02526784Phase 3
- Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial.CompletedNCT02526602Not applicable
- Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical ProstatectomyCompletedNCT02526589
- Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion DeviceStatus unknownNCT02524860Not applicable
- Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare PopulationCompletedNCT02518698
- Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate CancerCompletedNCT02516995Not applicable
- Linear Source Registry for Prostate CancerCompletedNCT02516709
- Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate CancerCompletedNCT02514213Phase 1
- Study of the Effect of Chemotherapy With Cabazitaxel on Prostate CancerCompletedNCT02512458Phase 2
- Towards Optimal Prescription of Chemotherapy in Prostate CancerCompletedNCT02512185
- Volume Controlled Ventilation vs Autoflow-volume Controlled VentilationWithdrawnNCT02512120Not applicable
- Metformin And LongevityStatus unknownNCT02511665Phase 4
- Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone MetastasisCompletedNCT02507570Phase 2
- Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study)CompletedNCT02507427Phase 1/2
- Prostate Cancer E-Health-TutorialCompletedNCT02503748Not applicable
- Phase 1 Study of GEN0101 in Patients With Recurrence of CRPCStatus unknownNCT02502994Phase 1
- Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate CancerCompletedNCT02499848Phase 2
- LIpitor and biGuanide to Androgen Delay TrialWithdrawnNCT02497638Phase 2
- European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)CompletedNCT02495974
- Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided BiopsyCompletedNCT02488096Not applicable
- Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate CancerTerminatedNCT02487823Phase 1
- Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy IncontinenceStatus unknownNCT02485665Not applicable
- Assessment of Prostate MRI Before Prostate BiopsiesCompletedNCT02485379Not applicable
- Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)Status unknownNCT02484339Phase 2
- PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate CancerTerminatedNCT02483884Phase 1/2
- Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate CancerStatus unknownNCT02481648Not applicable
- Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate CancerCompletedNCT02479945Not applicable
- Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate CancerTerminatedNCT02478125Phase 1
- Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI)TerminatedNCT02478112Not applicable
- Effects of an Interactive ICT-Platform for Assessment and Management of Symptoms in Patients Treated for Prostate CancerCompletedNCT02477137Not applicable
- Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone AgonistsCompletedNCT02475057Phase 4
- Physical Training and Cancer-a Multicenter Clinical TrialActive, not recruitingNCT02473003Not applicable
- PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate CancerCompletedNCT02472275Phase 1
- Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment ResponseCompletedNCT02471469
- Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8CompletedNCT02470936Not applicable
- Pharmacokinetics of Degarelix in Chinese Patients With Prostate CancerCompletedNCT02468284Phase 1
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- Carbon-11 Labeled Sarcosine in Prostate CancerCompletedNCT02462447
- Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical ProstatovesiculectomyStatus unknownNCT02460861Not applicable
- Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen DeprivationCompletedNCT02460549Not applicable
- Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate CancerTerminatedNCT02459912Phase 2
- Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate CancerCompletedNCT02458716Phase 1
- CTC Immune CheckpointCompletedNCT02456571